Vanguard World Fund. Holdings as of May 31, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| Eli Lilly & CoLLY | 14.04% | $2.67B | 2,413,444 |
| Johnson & JohnsonJNJ | 8.47% | $1.61B | 7,135,556 |
| AbbVie IncABBV | 6.09% | $1.16B | 5,307,975 |
| UnitedHealth Group IncUNH | 5.45% | $1.03B | 2,720,656 |
| Merck & Co IncMRK | 4.66% | $885.00M | 7,454,549 |
| Thermo Fisher Scientific IncTMO | 2.93% | $555.74M | 1,128,374 |
| Amgen IncAMGN | 2.87% | $544.66M | 1,617,212 |
| Gilead Sciences IncGILD | 2.64% | $500.92M | 3,726,237 |
| Intuitive Surgical IncISRG | 2.38% | $452.10M | 1,064,672 |
| Pfizer IncPFE | 2.35% | $447.04M | 17,075,747 |
| Abbott LaboratoriesABT | 2.35% | $447.02M | 5,222,149 |
| Bristol-Myers Squibb CoBMY | 1.84% | $349.61M | 6,114,287 |
| Danaher CorpDHR | 1.84% | $348.74M | 1,909,151 |
| CVS Health CorpCVS | 1.83% | $346.91M | 3,812,997 |
| Vertex Pharmaceuticals IncVRTX | 1.80% | $341.05M | 762,060 |
| Stryker CorpSYK | 1.66% | $315.33M | 1,033,559 |
| Medtronic PLCMDT | 1.50% | $284.14M | 3,849,568 |
| McKesson CorpMCK | 1.45% | $275.20M | 370,665 |
| Elevance Health IncELV | 1.35% | $256.81M | 653,140 |
| Cigna Group/TheCI | 1.17% | $222.56M | 802,292 |
| Boston Scientific CorpBSX | 1.13% | $215.12M | 4,452,909 |
| Regeneron Pharmaceuticals IncREGN | 1.00% | $190.73M | 310,237 |
| HCA Healthcare IncHCA | 0.96% | $181.61M | 479,764 |
| Edwards Lifesciences CorpEW | 0.79% | $150.72M | 1,742,975 |
| Cencora IncCOR | 0.79% | $149.07M | 553,417 |
| Cardinal Health IncCAH | 0.74% | $140.42M | 713,505 |
| IDEXX Laboratories IncIDXX | 0.71% | $135.15M | 239,830 |
| Becton Dickinson & CoBDX | 0.66% | $125.92M | 855,933 |
| Alnylam Pharmaceuticals IncALNY | 0.63% | $119.84M | 396,853 |
| Agilent Technologies IncA | 0.61% | $115.40M | 851,463 |
| Waters CorpWAT | 0.60% | $113.32M | 295,436 |
| Humana IncHUM | 0.58% | $110.35M | 361,318 |
| Zoetis IncZTS | 0.54% | $102.84M | 1,323,667 |
| IQVIA Holdings IncIQV | 0.49% | $93.23M | 511,679 |
| Natera IncNTRA | 0.46% | $88.21M | 394,919 |
| Centene CorpCNC | 0.46% | $88.01M | 1,476,719 |
| Dexcom IncDXCM | 0.46% | $86.40M | 1,171,689 |
| Biogen IncBIIB | 0.45% | $86.39M | 440,787 |
| GE HealthCare Technologies IncGEHC | 0.45% | $85.34M | 1,368,877 |
| ResMed IncRMD | 0.44% | $83.54M | 438,370 |
| Veeva Systems IncVEEV | 0.43% | $81.76M | 468,964 |
| REVOLUTION Medicines IncRVMD | 0.40% | $76.49M | 485,701 |
| Illumina IncILMN | 0.39% | $74.75M | 458,727 |
| Mettler-Toledo International IncMTD | 0.38% | $72.42M | 61,343 |
| West Pharmaceutical Services IncWST | 0.37% | $69.78M | 216,149 |
| Insmed IncINSM | 0.36% | $68.47M | 640,424 |
| United Therapeutics CorpUTHR | 0.36% | $68.43M | 122,899 |
| Quest Diagnostics IncDGX | 0.34% | $65.12M | 334,125 |
| Labcorp Holdings IncLH | 0.34% | $64.76M | 249,006 |
| STERIS PLCSTE | 0.33% | $62.70M | 294,734 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.